Stock KBLM 180 LIFE SCIENCES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages 180 Life Sciences Corp.

Equities

KBLM

US68236V3024

Market Closed - Nasdaq
Other stock markets
 21:30:00 29/04/2024 BST 		5-day change 1st Jan Change
1.96 USD +8.89% Intraday chart for 180 Life Sciences Corp. +3.16% -51.68%
03-25 180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-11 180 Life Sciences Corp. Announces Board Changes CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
180 Life Sciences Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
180 Life Sciences Corp. Announces Board Changes
180 Life Sciences Corp. Appoints Blair Jordan as A Member of the Board of Directors
180 Life Sciences to Conduct 1-For-19 Reverse Stock Split
180 Life Sciences Corp. Announces Board Resignations
180 Life Sciences Corp. Announces Resignation of Donald A. Mcgovern, as Member of the Board of Directors
180 Life Sciences Hires Financial Adviser to Help Explore Strategic Alternatives
180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
180 Life Sciences Announces Review of Strategic Alternatives
180 Life Sciences Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
180 Life Sciences Corp. Receives Formal Written Scientific Response from the United Kingdom's Medicines and Healthcare Products Regulatory Agency
180 Life Sciences Corp. and Oxford University Innovation Limited Enter into a Termination Letter, Formally Terminate the License
180 Life Sciences Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Top Premarket Gainers
180 Life Sciences Announces an Agreement for A Clinical Pharmacology Study Testing A New Formulation of Cbd for Enhanced Oral Uptake
180 Life Sciences Corp. Provides Update on Regulatory Approval Process in the UK and US for Dupuytren's Disease Treatment
180 Life Sciences Corp. Announces the Filing of A Provisional Patent Describing the Combination of CBD with GLP-1 Agonists to Suppress Appetite
180 Life Sciences Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
180 Life Sciences Closes Sale of 1.57 Million Shares for $3 Million in Proceeds
Sector Update: Healthcare Stocks Rising Late Afternoon
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KBLM Stock
  4. News 180 Life Sciences Corp.
  5. Other languages